Clinical trial / 2024
Active bioavailability of oral crystalline vitamin B12 saturated at approximately 1.2 µg in healthy adults.
In nine healthy adults, oral [13C]-cyanocobalamin bioavailability was evaluated at doses of 2.5, 5, and 10 µg in a randomized crossover design with a one-month washout. Percentage bioavailability decreased significantly at 50.9 ± 32.5%, 26.7 ± 22.3%, and 15.4 ± 13.6%, respectively (p < 0.01), while absolute bioavailability was 1.16 ± 0.74 µg, 1.22 ± 1.02 µg, and 1.39 ± 1.23 µg (p = 0.46). A combined meta-analysis revealed two phases: an active absorption process up to 2.6 µg with a slope of 43%/µg reaching a maximum of 1.2 µg, and a slope of 1%/µg at higher doses suggesting a passive process.
- Study type
- Randomized crossover trial and meta-analysis
- Who was studied
- Nine healthy Indian adults
- What was measured
- Dose-dependency and percentage/absolute bioavailability of [13C]-cyanocobalamin
THE PAPER
The Oral Bioavailability of Vitamin B12 at Different Doses in Healthy Indian Adults.
Kashyap S, Gowda P, Pasanna RM, Sivadas A, Sachdev HS, Kurpad AV, Devi S. Nutrients, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.